Dimeric-(−)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathway
Xiuli Sun(Peking University), Cheng‐Ting Zi(Yunnan Agricultural University), Xuanjun Wang(Chuxiong Normal University), Jun Sheng(Shanghai University of Traditional Chinese Medicine), Ning Zhang(Tianjin Children's Hospital), Lixia Wang(Second Affiliated Hospital of Nanjing Medical University), Dongying Zhang(Huaian First People’s Hospital), Zemin Xiang(Yunnan Agricultural University), Yi-Long Wu, Yin-Rong Xie(Yunnan Agricultural University)
Cited by 17
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
|Oncogene|2017|370
Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307